文献速递脑血管病

无症状颈动脉狭窄:TCAR与CAS的缺血性卒中结局比较

Transcarotid Artery Revascularization Versus Carotid Artery Stenting for Asymptomatic Carotid Stenosis
RSS 订阅 · Stroke

基于2016至2024年TriNetX多中心电子健康记录数据库,纳入无症状颈动脉狭窄并接受经颈动脉血运重建术(TCAR)或颈动脉支架植入术(CAS)的成人患者,经倾向评分匹配后各2207例。主要结局为4年内缺血性卒中,结果显示TCAR相比CAS未显著降低卒中风险(HR 0.68,95%CI 0.44-1.06)。随访期内绝对风险差的扩大趋势提示可能存在残余混杂,而非手术本身获益。

要点

  • TCAR相比CAS未显著降低无症状颈动脉狭窄患者的4年缺血性卒中风险。
  • 4年时卒中发生率TCAR为3.26%,CAS为4.81%,绝对差1.55%但无统计学意义。
  • 随访期间绝对风险差随时间扩大,作者认为提示残余混杂而非TCAR操作获益。

核心结论

  • 在无症状颈动脉狭窄患者中,TCAR未显著降低缺血性卒中风险,绝对风险差的扩大趋势提示残余混杂而非操作本身获益。

研究设计与样本

  • 使用2016至2024年TriNetX多中心联邦电子健康记录数据库进行回顾性队列研究。
  • 识别接受TCAR或CAS的无症状颈动脉狭窄成人患者,经倾向评分匹配后每组2207例。
  • 匹配变量包括人口学特征、实验室指标、危险因素、合并症和用药情况。
  • 主要结局为4年内缺血性卒中,采用风险比和绝对风险差进行评估。

主要发现

  • TCAR与CAS相比,4年内缺血性卒中风险比为0.68(95%CI 0.44-1.06),未达到统计学显著性。
  • 6个月时卒中发生率TCAR为0.61%,CAS为0.96%,绝对差0.35%(P=0.18)。
  • 4年时卒中发生率TCAR为3.26%,CAS为4.81%,绝对差1.55%(P=0.086)。
  • TCAR的绝对风险在随访期间数值上较低但无统计学意义,且差异随时间逐渐扩大。

临床怎么用

  • 该真实世界数据不支持在无症状颈动脉狭窄患者中优先选择TCAR以降低卒中风险。
  • 对于无症状颈动脉狭窄的血运重建方式选择,仍需结合患者个体情况和手术风险评估。

局限性

  • 绝对风险差随时间扩大,作者认为该趋势提示存在残余混杂而非TCAR操作本身获益。
  • 研究基于电子健康记录数据库,匹配后仍可能存在未测量的混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Volume 57, Issue 11, Page 3431-3437, November 1, 2026. BACKGROUND:The CREST-2 trial (Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial) demonstrated superiority of carotid artery stenting (CAS) over intensive medical management for asymptomatic carotid stenosis, but it did not evaluate transcarotid artery revascularization (TCAR). Herein, we compared ischemic stroke outcomes between TCAR and CAS among patients with asymptomatic carotid stenosis in contemporary real-world practice.METHODS:We identified adults with asymptomatic carotid stenosis undergoing TCAR versus CAS using the 2016 to 2024 TriNetX database, which is a multicenter federated database of electronic health records. Propensity score matching was performed for demographics, laboratory values, risk factors, comorbidities, and medications. The primary outcome was ischemic stroke within 4 years.RESULTS:Among 7303 identified patients, 2207 patients remained in each group after matching. TCAR did not demonstrate a significantly different stroke risk compared with CAS (hazard ratio, 0.68 [95% CI, 0.44–1.06]). The absolute risk difference was numerically but nonsignificantly lower for patients with TCAR throughout the follow-up period, progressively widening over time: 0.35% at 6 months (0.61% versus 0.96%;P=0.18) to 1.55% at 4 years (3.26% versus 4.81%;P=0.086).CONCLUSIONS:TCAR did not significantly lower stroke risk compared with CAS for asymptomatic carotid stenosis. Although nonsignificant trends towards lower stroke risk were observed for TCAR, the widening of absolute risk differences over time suggests residual confounding rather than potential procedural benefit.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:Transcarotid Artery Revascularization Versus Carotid Artery Stenting for Asymptomatic Carotid Stenosis

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。